Last reviewed · How we verify
Perianal NRL001 Gel 3 strengths
Perianal NRL001 Gel 3 strengths is a Small molecule drug developed by Norgine. It is currently in Phase 1 development. Also known as: methoxamine gel 0.3%, 1.0%, 3.0%.
At a glance
| Generic name | Perianal NRL001 Gel 3 strengths |
|---|---|
| Also known as | methoxamine gel 0.3%, 1.0%, 3.0% |
| Sponsor | Norgine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Perianal NRL001 Gel 3 strengths CI brief — competitive landscape report
- Perianal NRL001 Gel 3 strengths updates RSS · CI watch RSS
- Norgine portfolio CI
Frequently asked questions about Perianal NRL001 Gel 3 strengths
What is Perianal NRL001 Gel 3 strengths?
Perianal NRL001 Gel 3 strengths is a Small molecule drug developed by Norgine.
Who makes Perianal NRL001 Gel 3 strengths?
Perianal NRL001 Gel 3 strengths is developed by Norgine (see full Norgine pipeline at /company/norgine).
Is Perianal NRL001 Gel 3 strengths also known as anything else?
Perianal NRL001 Gel 3 strengths is also known as methoxamine gel 0.3%, 1.0%, 3.0%.
What development phase is Perianal NRL001 Gel 3 strengths in?
Perianal NRL001 Gel 3 strengths is in Phase 1.
Related
- Manufacturer: Norgine — full pipeline
- Also known as: methoxamine gel 0.3%, 1.0%, 3.0%
- Compare: Perianal NRL001 Gel 3 strengths vs similar drugs
- Pricing: Perianal NRL001 Gel 3 strengths cost, discount & access